Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
Farmer Mac is compounding a record rural-credit book with strong spread income and capital headroom, but AGM holders own non-voting common in a highly levered GSE whose thesis depends on funding access, agricultural credit quality, policy treatment and discipl
Tag facets appear after tag usage counts are rebuilt.
AGM.A is Farmer Mac's Class A voting common stock, with real board-election rights for eligible non-Farm Credit System financial institutions and the same declared common dividend as AGM, but ownership restrictions, narrow holder eligibility, related-party con
OpenCitigroup is a globally important bank with FY2025 revenue of $85.2 billion, Q1 2026 revenue of $24.6 billion and $1.45 trillion of deposits, but the thesis depends on deposit stability, credit, capital and simplification execution.
OpenBank of America reported FY2025 revenue of $113.1 billion, FY2025 net income of $30.5 billion and Q1 2026 net income of $8.6 billion. The thesis is deposit durability, capital discipline and credit quality through the rate cycle.
Open20/20 Biolabs has a real OneTest cancer-screening revenue base and a fresh Nasdaq listing, but FY2025 losses, negative cash flow, Streeterville financing and resale overhang keep AIDX in a high-risk coverage bucket.
OpenAssured Guaranty is a financial guaranty insurer with Q1 2026 new-business growth, record adjusted book value per share and a long buyback record, but the equity case still depends on ratings strength, insured-credit losses, PREPA and disciplined capital alloc
OpenAGNC is a leveraged Agency MBS mortgage REIT. Q1 2026 spread income covered the common dividend, but tangible book value fell and the common equity remains tied to mortgage spreads, repo funding, hedge performance and leverage.
OpenAegon is trying to simplify into a U.S.-centered Transamerica story by 2028, with FY2025 capital generation, WFG growth, legacy-risk cleanup, and a GBP 2.0 billion UK sale all pointing in the same direction.
OpenAdvanced Biomed has historical cancer-diagnostics technology, but the latest filings show no product revenue, a reverse split, a short-term loan, a subsidiary divestiture, and an April 2026 pivot into AI.
OpenAditxt's filings show a precommercial health-innovation platform with immune, diagnostic, infectious-disease, women's-health, and proteomics ambitions, but the source-backed decision point is Nasdaq survival, cash, dilution, and whether any program can outrun
OpenAdaptive's clonoSEQ MRD business is finally showing scale, but the proof gate is whether test volume, reimbursement, pharma milestones, and operating leverage can absorb cash burn and the OrbiMed revenue-interest obligation.
OpenEnact is profitable, overcapitalized against PMIERs, and returning cash through dividends and buybacks, but the public-company thesis still runs through mortgage credit, GSE rules, housing affordability, reinsurance markets, and Genworth's 81% control.
OpenOfficial-source baseline for Ameris Bancorp using SEC submissions, SEC company facts, the FY2025 10-K, Q1 FY2026 10-Q, Q1 2026 filed earnings release and presentation, proxy materials, and FDIC industry context.
OpenAclarion has a distinctive MRS-based spine diagnostic workflow, a stronger post-financing cash balance, and visible CLARITY and payer proof gates, but FY2025 revenue was only $75,730 and the company still has to convert Nociscan from clinical promise into reim
OpenAbbott's Medical Devices engine, led by diabetes care, is doing the heavy lifting while Nutrition weakens and the Exact Sciences acquisition adds cancer-diagnostics upside, debt, and integration risk.
OpenArbor's agency servicing platform gives the mortgage REIT a fee engine, but Q1 2026 still leaves investors underwriting loan modifications, foreclosures, REO impairments, leverage, and dividend coverage.
OpenACNB looks like a sleepy community bank until the filing trail shows a post-Traditions balance sheet reset, a 4.46% Q1 margin, low reported credit stress, and a board returning capital through a higher dividend, a special dividend, and a new buyback.
OpenOfficial-source baseline for Acadian Asset Management using SEC submissions, SEC XBRL companyfacts, the FY2025 10-K, Q1 FY2026 10-Q, Q1 FY2026 earnings presentation and 8-K, 2026 proxy, and competitor filings.
OpenAgilent's CrossLab mix and cash generation point to a durable lab-workflow franchise, but the open question is whether service and consumables strength can outrun instrument-cycle volatility.
OpenSigned-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
Tag facets appear after tag usage counts are rebuilt.